Kendra R. Adams

Kendra R. Adams

Chief Financial OfficeratC4 Therapeutics· In proxies 2023–2025

Pay in FY2025-33% from the year before · C4 Therapeutics stock -46.9% the same year

Kendra R. Adams was paid $1.5M in FY2025 (Dec), down 33%. C4 Therapeutics stock fell 46.9% that year.

Pay$100 in the stock at the end of FY22 → $32
Pay is from the Summary Compensation Table of each C4 Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. C4 TherapeuticsPublic company · 3 yr
    • Chief Financial Officer2023 – Present · 3 yrStock in role -37%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?